Christian Happi
#58,644
Most Influential Person Now
Cameroonian biologist
Christian Happi's AcademicInfluence.com Rankings
Christian Happibiology Degrees
Biology
#3443
World Rank
#5266
Historical Rank
Genetics
#962
World Rank
#1058
Historical Rank
Molecular Biology
#2516
World Rank
#2556
Historical Rank
Download Badge
Biology
Why Is Christian Happi Influential?
(Suggest an Edit or Addition)According to Wikipedia, Christian Happi is a Professor of Molecular Biology and Genomics in the Department of Biological Sciences and the Director of the African Centre of Excellence for Genomics of Infectious Diseases, both at Redeemer’s University. He is known for leading the team of scientists that used genomic sequencing to identify a single point of infection from an animal reservoir to a human in the Ebola outbreak in West Africa. His research focus is on infectious diseases, including malaria, Lassa fever, Ebola virus disease, HIV, and SARS-CoV-2.
Christian Happi's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak (2014) (1126)
- Clinical illness and outcomes in patients with Ebola in Sierra Leone. (2014) (491)
- Enabling the genomic revolution in Africa (2014) (327)
- Virus genomes reveal factors that spread and sustained the Ebola epidemic (2017) (319)
- Ebola Virus Epidemiology, Transmission, and Evolution during Seven Months in Sierra Leone (2015) (262)
- Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus (2015) (207)
- Streamlined inactivation, amplification, and Cas13-based detection of SARS-CoV-2 (2020) (194)
- Lassa Fever in Post-Conflict Sierra Leone (2014) (166)
- Molecular Diagnostics for Lassa Fever at Irrua Specialist Teaching Hospital, Nigeria: Lessons Learnt from Two Years of Laboratory Operation (2012) (140)
- Enhanced methods for unbiased deep sequencing of Lassa and Ebola RNA viruses from clinical and biological samples (2014) (129)
- Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits (2016) (128)
- Selection of Plasmodium falciparum Multidrug Resistance Gene 1 Alleles in Asexual Stages and Gametocytes by Artemether-Lumefantrine in Nigerian Children with Uncomplicated Falciparum Malaria (2008) (124)
- Reemergence of Human Monkeypox in Nigeria, 2017 (2018) (120)
- World Antimalarial Resistance Network (WARN) III: Molecular markers for drug resistant malaria (2007) (117)
- Association between mutations in Plasmodium falciparum chloroquine resistance transporter and P. falciparum multidrug resistance 1 genes and in vivo amodiaquine resistance in P. falciparum malaria-infected children in Nigeria. (2006) (114)
- In vitro cytotoxicity studies of 20 plants used in Nigerian antimalarial ethnomedicine. (2006) (113)
- Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria. (2005) (111)
- Urgent need for a non-discriminatory and non-stigmatizing nomenclature for monkeypox virus (2022) (111)
- Genomic Analysis of Lassa Virus during an Increase in Cases in Nigeria in 2018 (2018) (108)
- Molecular analysis of Plasmodium falciparum recrudescent malaria infections in children treated with chloroquine in Nigeria. (2004) (98)
- A Research Agenda for Malaria Eradication: Basic Science and Enabling Technologies (2011) (96)
- Genome-wide scans provide evidence for positive selection of genes implicated in Lassa fever (2012) (93)
- Nomenclature- and Database-Compatible Names for the Two Ebola Virus Variants that Emerged in Guinea and the Democratic Republic of the Congo in 2014 (2014) (92)
- Clinical and laboratory predictors of Lassa fever outcome in a dedicated treatment facility in Nigeria: a retrospective, observational cohort study. (2018) (89)
- Effectiveness of artemisinin-based combination therapy used in the context of home management of malaria: A report from three study sites in sub-Saharan Africa (2008) (82)
- Identification and Functional Validation of the Novel Antimalarial Resistance Locus PF10_0355 in Plasmodium falciparum (2011) (80)
- Capturing sequence diversity in metagenomes with comprehensive and scalable probe design (2019) (76)
- Deployable CRISPR-Cas13a diagnostic tools to detect and report Ebola and Lassa virus cases in real-time (2020) (65)
- Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variants (2022) (61)
- Discovery of Novel Rhabdoviruses in the Blood of Healthy Individuals from West Africa (2015) (55)
- Activities of Amodiaquine, Artesunate, and Artesunate-Amodiaquine against Asexual- and Sexual-Stage Parasites in Falciparum Malaria in Children (2007) (54)
- Potential contribution of prescription practices to the emergence and spread of chloroquine resistance in south-west Nigeria: caution in the use of artemisinin combination therapy (2009) (53)
- Filovirus RefSeq Entries: Evaluation and Selection of Filovirus Type Variants, Type Sequences, and Names (2014) (53)
- Therapeutic efficacy and effects of artemether-lumefantrine and amodiaquine-sulfalene-pyrimethamine on gametocyte carriage in children with uncomplicated Plasmodium falciparum malaria in southwestern Nigeria. (2007) (53)
- A qualitative study of the feasibility and community perception on the effectiveness of artemether-lumefantrine use in the context of home management of malaria in south-west Nigeria (2008) (53)
- In vitro amodiaquine resistance and its association with mutations in pfcrt and pfmdr1 genes of Plasmodium falciparum isolates from Nigeria. (2011) (52)
- Roots, Not Parachutes: Research Collaborations Combat Outbreaks (2016) (48)
- Factors contributing to delay in parasite clearance in uncomplicated falciparum malaria in children (2010) (36)
- Effects of amodiaquine, artesunate, and artesunate-amodiaquine on Plasmodium falciparum malaria-associated anaemia in children. (2009) (36)
- Emerging Disease or Diagnosis? (2012) (34)
- Prevalence of Lassa Virus Disease (LVD) in Nigerian children with fever or fever and convulsions in an endemic area (2017) (34)
- Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever (2018) (34)
- Caseload and Case Fatality of Lassa Fever in Nigeria, 2001–2018: A Specialist Center's Experience and Its Implications (2019) (33)
- An Outbreak of Ebola Virus Disease in the Lassa Fever Zone. (2016) (31)
- In vitro-reduced susceptibility to artemether in P. falciparum and its association with polymorphisms on transporter genes. (2012) (30)
- Plasmodium falciparum gametocyte sex ratios in symptomatic children treated with antimalarial drugs. (2009) (30)
- Therapeutic efficacies of artemisinin-based combination therapies in Nigerian children with uncomplicated falciparum malaria during five years of adoption as first-line treatments. (2011) (28)
- Empowering African genomics for infectious disease control (2014) (28)
- Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and death (2019) (28)
- Genomic analysis of Lassa virus from the 2018 surge in Nigeria (2018) (28)
- Factors contributing to anaemia after uncomplicated falciparum malaria in under five year-old Nigerian children ten years following adoption of artemisinin-based combination therapies as first-line antimalarials (2017) (27)
- Early variations in plasmodium falciparum dynamics in Nigerian children after treatment with two artemisinin-based combinations: implications on delayed parasite clearance (2010) (27)
- Plasmodium falciparum gametocyte sex ratios in children with acute, symptomatic, uncomplicated infections treated with amodiaquine (2008) (27)
- Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa (2006) (27)
- Comparison of SYBR Green I-, PicoGreen-, and [3H]-hypoxanthine-based assays for in vitro antimalarial screening of plants from Nigerian ethnomedicine (2010) (26)
- Therapeutic efficacy and effects of artemether-lumefantrine and artesunate-amodiaquine coformulated or copackaged on malaria-associated anemia in children with uncomplicated Plasmodium falciparum malaria in Southwest Nigeria. (2011) (26)
- Rapid detection of lactate dehydrogenase and genotyping of Plasmodium falciparum in saliva of children with acute uncomplicated malaria. (2010) (26)
- Retrospective Cohort Study of Lassa Fever in Pregnancy, Southern Nigeria (2019) (25)
- Lassa fever diagnostics: past, present, and future. (2019) (25)
- Tracking the emergence of new SARS-CoV-2 variants in South Africa (2021) (23)
- Therapeutic efficacy and effects of artesunate-mefloquine and mefloquine alone on malaria-associated anemia in children with uncomplicated Plasmodium falciparum malaria in southwest Nigeria. (2009) (23)
- Factors contributing to anaemia after uncomplicated Plasmodiumfalciparum malaria in children. (2010) (23)
- African Resources and the Promise of Resilience against COVID-19 (2020) (23)
- Ebola Virus Epidemiology and Evolution in Nigeria (2016) (22)
- Population structure of Plasmodium falciparum gametocyte sex ratios in malarious children in an endemic area. (2009) (21)
- Plasmodium falciparum gametocyte carriage, sex ratios and asexual parasite rates in Nigerian children before and after a treatment protocol policy change instituting the use of artemisinin-based combination therapies. (2011) (21)
- Efficacy of Artemisinin-Based Combination Treatments of Uncomplicated Falciparum Malaria in Under-Five-Year-Old Nigerian Children Ten Years Following Adoption as First-Line Antimalarials. (2018) (21)
- Real-time Metagenomic Analysis of Undiagnosed Fever Cases Unveils a Yellow Fever Outbreak in Edo State, Nigeria (2019) (20)
- High crossreactivity of human T cell responses between Lassa virus lineages (2020) (20)
- Feasibility, acceptability and use of artemisinin-based combination therapy (2010) (20)
- Simplified Cas13-based assays for the fast identification of SARS-CoV-2 and its variants (2022) (20)
- Different patterns of pfcrt and pfmdr1 polymorphisms in P. falciparum isolates from Nigeria and Brazil: the potential role of antimalarial drug selection pressure. (2012) (19)
- Accelerating genomics-based surveillance for COVID-19 response in Africa (2020) (18)
- Recrudescent Plasmodium falciparum infections in children in an endemic area following artemisinin–based combination treatments: Implications for disease control (2011) (17)
- Activities of Artemether-Lumefantrine and Amodiaquine-Sulfalene-Pyrimethamine against Sexual-Stage Parasites in Falciparum Malaria in Children (2008) (17)
- Effects of mefloquine and artesunate mefloquine on the emergence, clearance and sex ratio of Plasmodium falciparum gametocytes in malarious children (2009) (17)
- Linkage disequilibrium between two distinct loci in chromosomes 5 and 7 of Plasmodium falciparum and in vivo chloroquine resistance in Southwest Nigeria (2006) (16)
- Plasmodium falciparum gametocyte carriage, emergence, clearance and population sex ratios in anaemic and non-anaemic malarious children. (2011) (16)
- Current and emerging strategies for the diagnosis, prevention and treatment of Lassa fever (2015) (15)
- Use of Area Under the Curve to Evaluate the Effects of Antimalarial Drugs on Malaria-Associated Anemia After Treatment (2011) (15)
- Declining responsiveness of childhood Plasmodium falciparum infections to artemisinin-based combination treatments ten years following deployment as first-line antimalarials in Nigeria (2019) (15)
- Risk factors for Plasmodium falciparum hyperparasitaemia in malarious children (2011) (14)
- Comparative study of interactions between chloroquine and chlorpheniramine or promethazine in healthy volunteers: a potential combination-therapy phenomenon for resuscitating chloroquine for malaria treatment in Africa (2008) (14)
- malERA: An updated research agenda for basic science and enabling technologies in malaria elimination and eradication (2017) (13)
- Effects of acute Plasmodium falciparum malaria on body weight in children in an endemic area (2007) (13)
- Characterization of Plasmodium falciparum structure in Nigeria with malaria SNPs barcode (2018) (13)
- Therapeutic efficacy and effects of artemisinin-based combination treatments on uncomplicated Plasmodium falciparum malaria -associated anaemia in Nigerian children during seven years of adoption as first-line treatments (2017) (13)
- A high performance liquid chromatographic assay of Mefloquine in saliva after a single oral dose in healthy adult Africans (2012) (12)
- Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages (2020) (12)
- Plasmodium falciparum hyperparasitaemia in Nigerian children: epidemiology, clinical characteristics, and therapeutic responses to oral artemisinin-based combination treatments (2011) (12)
- Lassa fever awareness and practices in a nigerian rural community (2010) (12)
- Malaria diagnosis: false negative parasight-F tests in falciparum malaria patients in Nigeria. (2004) (11)
- Enhancement of the antimalarial efficacy of amodiaquine by chlorpheniramine in vivo. (2007) (11)
- Acute Lassa Virus Encephalitis with Lassa Virus in the Cerebrospinal Fluid but Absent in the Blood: A Case Report with a Positive Outcome (2018) (11)
- Effects of artesunate-cotrimoxazole and amodiaquine-artesunate against asexual and sexual stages of Plasmodium falciparum malaria in Nigerian children (2008) (11)
- Field evaluation of a Pan-Lassa rapid diagnostic test during the 2018 Nigerian Lassa fever outbreak (2020) (10)
- Fall in Hematocrit per 1000 Parasites Cleared From Peripheral Blood: A Simple Method for Estimating Drug-Related Fall in Hematocrit After Treatment of Malaria Infections (2014) (10)
- Virus genomes reveal the factors that spread and sustained the West African Ebola epidemic (2016) (9)
- Identification of Common CD8+ T Cell Epitopes from Lassa Fever Survivors in Nigeria and Sierra Leone (2020) (9)
- Capturing diverse microbial sequence with comprehensive and scalable probe design (2018) (8)
- Herpes simplex labialis in children with acute falciparum malaria. (2008) (8)
- Equipment-free detection of SARS-CoV-2 and Variants of Concern using Cas13 (2021) (8)
- Lassa fever practice challenges in Nigeria (2012) (8)
- Polymorphisms in Plasmodium falciparum chloroquine resistance transporter (Pfcrt) and multidrug-resistant gene 1 (Pfmdr-1) in Nigerian children 10 years post-adoption of artemisinin-based combination treatments. (2020) (8)
- Risk Factors for Gametocyte Carriage in Uncomplicated Falciparum Malaria in Children before and after Artemisinin-Based Combination Treatments (2012) (8)
- Interaction between rifampicin, amodiaquine and artemether in mice infected with chloroquine resistant Plasmodium berghei (2014) (7)
- A simple cost-effective high performance liquid chromatographic assay of sulphadoxine in whole blood spotted on filter paper for field studies (2009) (7)
- Biosafety level-2 laboratory diagnosis of Zaire Ebola virus disease imported from Liberia to Nigeria (2016) (7)
- New lessons from a case series review of Lassa fever in pregnancy (2010) (7)
- Early Changes in Plasmodium falciparum Asexual and Sexual Populations in Children with Acute Infections Following Treatment with Artemisinin-Based Combination Drugs (2012) (7)
- Early rising asexual parasitaemia in Nigerian children following a first dose of artemisinin-based combination treatments of falciparum malaria (2017) (7)
- Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial (2021) (6)
- Interaction between ciprofloxacin and chloroquine in mice infected with chloroquine resistant Plasmodium berghei (2012) (6)
- Anaemia following Artemisinin-Based Combination Treatments of Uncomplicated Plasmodium falciparum Malaria in Children: Temporal Patterns of Haematocrit and the Use of Uncomplicated Hyperparasitaemia as a Model for Evaluating Late-Appearing Anaemia (2017) (6)
- Amodiaquine–Ciprofloxacin: a potential combination therapy against drug resistant malaria (2015) (6)
- Polymorphisms in Plasmodium falciparum dihydropteroate synthetase and dihydrofolate reductase genes in Nigerian children with uncomplicated malaria using high-resolution melting technique (2021) (6)
- The Bacteria Genome Pipeline (BAGEP): an automated, scalable workflow for bacteria genomes with Snakemake (2020) (6)
- A Simple Dose Regimen of Artesunate and Amodiaquine Based on Age or Body Weight Range for Uncomplicated Falciparum Malaria in Children: Comparison of Therapeutic Efficacy With Standard Dose Regimen of Artesunate and Amodiaquine and Artemether–Lumefantrine (2012) (6)
- 0355 in Plasmodium falciparum (2011) (6)
- Dihydroartemisinin suppository in moderately severe malaria: comparative efficacy of dihydroartemisinin suppository versus intramuscular artemeter followed by oral sulfadoxine-pyrimethamine in the management of moderately severe malaria in Nigerian children. (2007) (6)
- Pharmacokinetic Disposition of Sulfadoxine in Children with Acute Uncomplicated Falciparum Malaria Treated with Sulfadoxine–Pyrimethamine in South West Nigeria (2012) (5)
- Detection of Antibody and Antigen for Lassa Virus Nucleoprotein in Monkeys from Southern Nigeria (2019) (5)
- Genetic diversity and population structure of Plasmodium falciparum in Nigeria: insights from microsatellite loci analysis (2021) (5)
- Oral artesunate-amodiaquine and artemether-lumefantrine in the treatment of uncomplicated hyperparasitaemic Plasmodium falciparum malaria in children. (2012) (5)
- Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and SARS-CoV-2 variants (2021) (5)
- The effects of alpha1-acid glycoprotein on the reversal of chloroquine resistance in Plasmodium falciparum. (2006) (5)
- Whole genome sequencing of clinical samples reveals extensively drug resistant tuberculosis (XDR TB) strains from the Beijing lineage in Nigeria, West Africa (2021) (4)
- Acute Kidney Injury and Mortality in Pediatric Lassa fever versus Question of Access to Dialysis. (2020) (4)
- Insights into the Nigerian COVID19 Outbreak (2020) (4)
- The effects of artemether–lumefantrine vs amodiaquine–sulfalene–pyrimethamine on the hepatomegaly associated with Plasmodium falciparum malaria in children (2006) (4)
- Metagenomic sequencing characterizes a wide diversity of viruses in field mosquito samples in Nigeria (2021) (4)
- Therapeutic Efficacy of Artesunate–Amodiaquine Combinations and the Plasma and Saliva Concentrations of Desethylamodiaquine in Children With Acute Uncomplicated Plasmodium falciparum Malaria (2013) (4)
- Influence of Anemia on Plasmodium falciparum Gametocyte Sex Ratios in Acutely Symptomatic Children (2008) (4)
- Development of a qualitative real-time RT-PCR assay for the detection of SARS-CoV-2: a guide and case study in setting up an emergency-use, laboratory-developed molecular microbiological assay (2021) (4)
- The Origins and Future of Sentinel: An Early-Warning System for Pandemic Preemption and Response (2021) (4)
- Microbial metagenomic approach uncovers the first rabbit haemorrhagic disease virus genome in Sub-Saharan Africa (2020) (4)
- New nomenclature for mpox (monkeypox) and monkeypox virus clades (2023) (3)
- Spatial and temporal trends of the Lassa fever epidemic in Nigeria 2001 – 2009, with particular reference to the Edo State experience (2010) (3)
- Parasite reduction ratio one day after initiation of artemisinin-based combination therapies and its relationship with parasite clearance time in acutely malarious children (2018) (3)
- Characterization of Plasmodium falciparum structure in Nigeria with malaria SNPs barcode (2018) (3)
- Lassa Virus Genetics. (2020) (3)
- Molecular surveillance of shiga toxigenic Escherichia coli in selected beef abattoirs in Osun State Nigeria (2021) (3)
- Development of a qualitative real-time RT-PCR assay for the detection of SARS-CoV-2: A guide and case study in setting up an emergency-use, laboratory-developed molecular assay (2020) (3)
- Clinical and laboratory predictors of Lassa fever outcome in a dedicated treatment facility in Nigeria: an observational cohort study (2018) (3)
- Some features of primary and recrudescent amodiaquine-resistant Plasmodium falciparum infections in Nigerian children. (2008) (3)
- Prevalence and presentation of Lassa fever in Nigerian children (2010) (3)
- Emergence and Genomic Characterization of Multidrug Resistant Candida auris in Nigeria, West Africa (2022) (3)
- HIV-1 drug resistance and genetic diversity in a cohort of people with HIV-1 in Nigeria (2021) (2)
- Kinetics of Plasmodium falciparum Gametocyte Sex Ratios: Application to the Evaluation of the Potential of Antimalarial Drugs to Influence Malaria Transmission (2011) (2)
- Risk factors for Lassa fever in endemic communities of Edo State, Nigeria (2014) (2)
- Dealing with the unseen: Ffear and stigma in lassa fever (2014) (2)
- First Report of Wolbachia from Field Populations of Culex Mosquitoes in South-Western Nigeria (2019) (2)
- 52 Years of Lassa Fever Outbreaks in Nigeria, 1969-2020: An Epidemiologic Analysis of the Temporal and Spatial Trends. (2021) (2)
- A modified anthrax toxin-based enzyme-linked immunospot assay reveals robust T cell responses in symptomatic and asymptomatic Ebola virus exposed individuals (2018) (2)
- Molecular profiling of the artemisinin resistance Kelch 13 gene in Plasmodium falciparum from Nigeria (2022) (2)
- Feasibility, acceptability and use of artemisinin-based combination therapy for home management of malaria in south-west Nigeria (2009) (1)
- Atypical serologic profiles of hepatitis B virus infection across clinical cohorts of patients in Southwestern Nigeria (2023) (1)
- Emergence and spread of two SARS-CoV-2 variants of interest in Nigeria (2023) (1)
- Corrigendum: Caseload and Case Fatality of Lassa Fever in Nigeria, 2001–2018: A Specialist Center's Experience and Its Implications (2019) (1)
- Increased Prevalence of Lassa Fever Virus-Positive Rodents and Diversity of Infected Species Found during Human Lassa Fever Epidemics in Nigeria (2022) (1)
- Efficacy and safety of nitazoxanide combined with ritonavir-boosted atazanavir for the treatment of mild to moderate COVID-19 (2022) (1)
- A high performance liquid chromatographic assay of Mefloquine in saliva after a single oral dose in healthy adult Africans (2012) (1)
- Adherence to COVID-19 preventive measures in Sub-Saharan Africa during the 1st year of the pandemic: Pooled analysis of the International Citizen Project on COVID-19 (ICPCovid) surveys (2022) (1)
- Interaction between rifampicin, amodiaquine and artemether in mice infected with chloroquine resistant Plasmodium berghei (2014) (1)
- A simple dose regimen of artesunate and amodiaquine based on arm span- or age range for childhood falciparum malaria: a preliminary evaluation. (2012) (1)
- Enhanced methods for unbiased deep sequencing of Lassa and Ebola RNA viruses from clinical and biological samples (2014) (1)
- VGEA: an RNA viral assembly toolkit (2021) (1)
- Capturing sequence diversity in metagenomes with comprehensive and scalable probe design (2019) (0)
- Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever (2018) (0)
- Interaction between ciprofloxacin and chloroquine in mice infected with chloroquine resistant Plasmodium berghei (2011) (0)
- Challenges and Opportunities in Lassa fever Control Efforts in Nigeria (2021) (0)
- Design, Implementation, and Coordination of Malaria Therapeutic Efficacy Studies in Nigeria in 2018. (2023) (0)
- Genetic diversity and population structure of Plasmodium falciparum in Nigeria: insights from microsatellite loci analysis (2021) (0)
- Pan-Genome Analysis of Mycobacterium Africanum: Insights to Dynamics and Evolution. (2020) (0)
- Real-time Metagenomic Analysis of Undiagnosed Fever Cases Unveils a Yellow Fever Outbreak in Edo State, Nigeria (2020) (0)
- Emergence and Genomic Characterization of Multidrug resistant Candida auris in West Africa (2022) (0)
- Pan-genome analysis of Mycobacterium africanum: insights to dynamics and evolution (2020) (0)
- Preventing Ebola Resurgence from Zoonotic Routes: A Random Assessment of Bat Populations in Osun State, Nigeria (2016) (0)
- Empowering African genomics for infectious disease control (2014) (0)
- Candida (Diutina) mesorugosa in Non-Albicans Candida Species Clinical Isolates in Southwest Nigeria (2020) (0)
- Molecular Detection and Prevalence of Non-O157 Shiga Toxigenic Escherichia Coli in Selected Chicken Abattoirs and Retail Outlets in Osogbo, Osun State Nigeria (2021) (0)
- Contents Vol. 57, 2011 (2012) (0)
- A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)–Study protocol (2023) (0)
- Molecular surveillance of non-O157 Shiga toxigenic Escherichia coli in selected chicken abattoirs and retail outlets in Osogbo, Osun State, Nigeria (2022) (0)
- Preparing for the next Ebola outbreak: in-country genomic capacity in Africa. (2019) (0)
- Title: in Vitro Antimalarial Susceptibility and Molecular Markers of Drug Resistance in Franceville, Gabon (0)
- Detection of Alpha- and Betacoronaviruses in Frugivorous and Insectivorous Bats in Nigeria (2022) (0)
- A randomized, open-label trial of combined nitazoxanide and atazanavir/ritonavir for mild to moderate COVID-19 (2022) (0)
- Clinical illness and outcomes in Nigerian children with persistent early-appearing anaemia following initiation of artemisinin-based combination treatments of uncomplicated falciparum malaria (2019) (0)
- Effective management of malaria is focused on use of long-lasting insecticidal nets, indoor residual spraying of insecticides, intermittent preventive therapy in pregnancy, and treatment of acute infections with artemisinin-based com- (2010) (0)
- Lassa Fever in Post-Conflict Sierra Leone The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters (2014) (0)
- Field evaluation of a Pan-Lassa rapid diagnostic test during the 2018 Nigerian Lassa fever outbreak (2020) (0)
- Genetic Diversity and Population Structure of Plasmodium Falciparum in Nigeria: Insights From Microsatellites Loci Analysis (2020) (0)
- Humoral and cellular immune responses to Lassa fever virus in Lassa fever survivors and their exposed contacts in Southern Nigeria (2022) (0)
- The Prevalence of Undiagnosed Salmonella enterica Serovar Typhi in Healthy School-Aged Children in Osun State, Nigeria (2023) (0)
This paper list is powered by the following services:
Other Resources About Christian Happi
What Schools Are Affiliated With Christian Happi?
Christian Happi is affiliated with the following schools:
